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Introduction. Several evidences show that muscles have an endocrine function. Glucocorticoid, estrogen, progesterone, and
testosterone receptors have already been found in normal skeletal muscles, but not in dystrophic muscles. Methods. e gene
expression of hormone receptors was compared between dystrophic and healthy muscles in mdx and C57BL6 mice strains.
Results. e mdx mice showed a signi�cant increase in the steroid receptors mR�A when compared to the C57BL6 mice: levels
of androgen(s) receptors in the heart, estrogen receptors alpha in the EDL, and estrogen receptors beta in the quadriceps were
increased. In addition, signi�cant lowered levels of some other hormone receptors were found: corticosteroid receptors in the EDL
and estrogen receptors alpha in the quadriceps. Conclusion. Dystrophic muscles bear signi�cant diﬀerences in the expression of
hormone receptors when compared to the C57BL6 mice strain. e importance of such diﬀerences is yet to be better understood.
1. Introduction
Duchennemuscular dystrophy (DMD) is anX-linked genetic
disorder resulting in a defect in themusclemembrane protein
called dystrophin. In the literature, there are more than
thirty catalogued types of dystrophies. However, DMD is
the most common kind, which aﬀects 1 in every 3,500
male births. e disease initially manifests itself by muscular
strength alterations, making the individual progressively lose
the ability to walk and �nally causing a reduction of the
cardiac function and the respiratory muscles strength [1].
e most widely used experimental model for studying
the disease is the mdx mouse. is kind of mouse bears a
point mutation in the dystrophin gene. e mdx mutation
occurred spontaneously due to a premature stop codon
resulting in a termination in exon 23 of the dystrophin gene.
e absence of dystrophin in mice produces a variety of
phenotypes, higher than that observed in humans. Under
normal conditions, the mdx mice show very few symptoms
of the disease, and when subjected to intensive exercises, they
present aggravation of the pathological alterations [2].
Corticosteroids are the only recommended treatment for
DMD. e drug increases muscle strength and slows the
onset of complications [1]. As muscles have an endocrine
function and due to the fact that this disease causes muscle
degeneration, the study of hormone receptors in these organs
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are of paramount importance. e mechanism of action of
corticosteroids in DMD has not been fully elucidated [3].
Several evidences demonstrate that muscles have an
endocrine function. erefore, the study of hormone recep-
tors in muscles has shown to be important. ese hormones
have an important role in the protein synthesis and degra-
dation, in the increase of muscle strength, and in the muscle
protection against the damage caused by exercises, facts that
make relevant the quanti�cation of hormone receptors in
dystrophic muscles.
e aim of this study was to evaluate the expression
of hormone receptors in dystrophic muscles in mdx mice,
comparing it with the expression of receptors in healthy
muscles in C57BL6 mice.
2. Material andMethods
All procedures used in this study were approved and per-
formed in accordance with the guidelines of the Animal Ethic
Committee of FMABC.
Ten four-month-old mice, being �ve mdx and �ve
C57BL6 strains, were studied. e latter was classi�ed as
control group.e animals were kept in spontaneous activity,
with food and water ad libitum, and later sacri�ced in a CO2
chamber. Some muscles, like the cardiac, the gastrocnemius,
the diaphragm, the quadriceps, the soleus, and the exten-
sorum digitalis longus (EDL), from both mice strains were
dissected, frozen in liquid nitrogen, and stored at −80∘C.
Total tissue RNA was extracted using Trizol Reagent
(Invitrogen Co., USA), according to the manufacturer’s
instructions, quanti�ed by absorbance at 260 nm, and stored
in diethylpyrocarbonate-treated water at−80∘C.e integrity
of RNAwas veri�ed by agarose gel electrophoresis. Total RNA
(2 ug) was used for �rst-strand cDNA synthesis by reverse
transcriptase. MMLV and RNaseOUT were also added to
protect the RNA during the process.
An aliquot of the reaction was then submitted to PCR
ampli�cation with the appropriate primers. Alpha-actin was
used as an internal control for the coampli�cation. e
conditions for PCR were as follows: initial denaturation
at 94∘C for 5 minutes, followed by cycles of 94∘C for 45
seconds, annealing of the temperature for 45 seconds, and
72∘C for 1 minute. e �nal extension step occurs at 72∘C
for 10 minutes. e primers sequence(s), size of the PCR
products, the annealing temperature, the number of cycles,
the accession numbers of the target sequences, and the
reactions conditions are presented in Table 1.
ree pooledRNAaliquotswere omitted from the reverse
transcriptase reaction to ensure the absence of products
other than those originated from the reverse-transcribed
mRNAs. PCR products were loaded in 1% or 2% agarose gel
electrophoresis, stained with 0.2 ug/mL ethidium bromide.
e gel was subjected to ultraviolet light and photographed.
e bands intensity was quanti�ed by video densitometry
and the signals were expressed in relation to the intensity
of the alpha-actin amplicon in each coampli�ed sample. All
primers and enzymes used in this protocol were purchased
from Invitrogen Co. e results were subjected to analysis of
variance, using the programGBStat and considering the level
of signi�cance 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃.
3. Results
e results of the mRNA of the mice were placed in Table 2.
Mdx mice showed signi�cant raise in the expression of
steroidal receptors mRNA when compared to the C57BL6
mice: androgen receptors in the heart, estrogen receptors
alpha in the EDL, and estrogen receptors beta in the quadri-
ceps were increased. In addition, signi�cant lowered levels
of some other hormone receptors were found: corticosteroid
receptors in the EDL and estrogen receptors alpha in the
quadriceps.
4. Discussion
Muscles express steroid receptors that belong to the super-
family of intracellular receptorswhich control gene transcrip-
tion. e eﬀect is to induce or repress particular genes [4–6].
e biological eﬀects of corticosteroids are mediated by
glucocorticoid receptors [6]. ese eﬀects include control of
salt/water homeostasis, blood pressure regulation, metabolic
alterations, and cellular immunity [5]. Glucocorticoids have
catabolic eﬀect on skeletal muscles and, in high doses, they
can cause a steroid myopathy [6]. e muscles most aﬀected
by corticosteroids are the quadriceps and the other muscles
of the pelvic girdle, being type IIb �bers the most susceptible
to this eﬀect. Exercises are eﬀective in preventing steroid
myopathy [7].
e catabolic eﬀects of glucocorticoids are mediated
by numerous mechanisms. Glucocorticoids inhibit glucose
uptake in skeletalmuscles andmay contribute to the degrada-
tion of muscle proteins. ey may also act directly to inhibit
the protein synthesis or increase its degradation. One of the
genes responsible for this eﬀect encodes the glutamine syn-
thetase, an enzyme responsible for catalyzing the formation
of glutamine that is exported from the muscle in catabolic
conditions. In muscular atrophy induced by glucocorticoids,
the eﬄux of glutamine is 25–30% of the total exported protein
of themuscle. In rats, an increase of glutamine synthetase and
the level of mRNA were observed aer the administration
of glucocorticoids. Another eﬀect of glucocorticoids is the
activation of genes responsible for the ubiquitin-proteasome
system, increasing the proteolytic activity in the muscle.
It is clear that the transactivation of many genes must be
involved in muscle atrophy by corticosteroids. e increase
of myostatin, a well-known protein inhibitor of muscle mass,
has also been observed with the use of glucocorticoids [6, 8].
Androgens, unlike glucocorticoids, exert an anabolic
eﬀect onmuscles.e anabolic eﬀects of androgens in skeletal
muscles have been a source of controversy for more than
six decades. Testosterone supplementation increases muscle
mass in men; this eﬀect is associated with hypertrophy of
�bers type I and II with an increase of satellite cells and
myonuclei. e mechanism by which testosterone increases
muscle mass is poorly understood. Although the expression
of androgen receptors have been described in muscle cells,
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T 1: RT-PCR analysis of various mRNAs: primes, size of the PCR products and conditions of the PCR reactions.
Gene Primers sequence Size of PCRproduct
Temperature
(∘C)
Number of
cycles
Accession
number at
http://ncbi.nlm.
nih.gov/
Androgen receptor
Sense: TACAACTTTCCGCTGGCTCT
Antisense:
CCGGAGTAGTTCTCCATCCA
464 58 30 NM013476.2
Glucocorticoid
receptor
Sense: CGAGAGTCCTTGGAGGTCAG
Antisense:
GATCCTGCTGCTGAGAAAGG
410 55 24 X13358
Estrogen receptor
Alpha
Sense:
AATTCTGACAATCGACGCCAG
Antisense:
GTGCTTCAACATTCTCCCTCCTC
344 55 30 or 40∗ NM007956
Estrogen receptor
Beta
Sense: ACAGTCCTGCTGTGATGAAC
Antisense:
ACTAGTAACAGGGCTGGCAC
271 55 30 or 40∗ U81451
Progesterone receptor
Sense: CCAGCATGTCGTCTGAGAAA
Antisense:
AAACACCATCAGGCTCATCC
426 60 40 NM008829
𝛼𝛼-Actin
Sense:
TGTGATGGTGGGAATGGGTCAG
Antisense:
TTGATGTCACGCACGATTTCC
513 55 28 AK151136
∗
Number of cycles varies with the saturation curve by the cycle of each tissue.
it is not clear which cells express this receptor and what the
target of its action is [9]. Recent studies have shown that
androgens promote the diﬀerentiation of lineages of mes-
enchymal pluripotent cells into myogenic cells and inhibit
the diﬀerentiation into cell lineages of adipose tissue. is
eﬀect is blocked by androgen receptor antagonists, indicating
that this eﬀect may be mediated through these receptors [9].
Testosterone receptor expression is observed in almost all
satellite cells and in 50% of myonuclei [9]. Physical activity
also plays a role in the expression of the androgen receptor.
In rats subjected to prolonged and intense physical activity,
there was an increase of the expression of androgen receptors
in the soleus, but not in the EDL [10].
Estrogens also play an important role in skeletal muscles,
regulating lipid and carbohydrate metabolism and acting on
the muscle growth and strength [11–14].
Alpha and beta receptors are expressed in skeletalmuscles
in both men and women [15]. Many studies suggest that
estrogens increase muscle strength, and variations in the
voluntary muscle strength were observed in humans during
the menstrual cycle [13, 14]. In other studies, there was
no change in the muscle function with increased estrogen
levels or �uctuations during the menstrual cycle [16, 17].
In female rats, the eccentric muscle contractions cause less
histological changes than inmale rats [18]. In ovariectomized
rats, there is a greater expression of proteins related to
stress and a greater degree of injury compared to normal
female rats. is diﬀerence disappears upon cessation of
estrogen treatment [19, 20]. Intense and prolonged physical
activity increases the expression of alpha receptor mRNA in
the gastrocnemius muscle in female rats, but not in male
rats [21]. e expression of estrogen receptors alpha and
beta is increased in men undergoing physical exercises. e
mRNA of estrogen receptors alpha and beta is increased in
highly trained men than in moderately trained ones, and
that expression is correlated with muscle oxidative capacity.
Estrogen receptors can be regulated by physical activities and
may be involved in the process of adaptation to physical
exercises [22]. Estrogen receptor alpha mRNA expression is
higher in the soleus than in the gastrocnemius or the EDL
[23].
ere are few studies of hormone receptors and hormone
eﬀects in dystrophic muscles.
Dubois and Almon [24] described a 100% increase in
corticosteroid receptors in the leg muscles of mice with
muscular dystrophy in relation to the control group; this
increase was also found in chickens with muscular dystrophy
[25].
e use of anabolic androgenswas also tested inmuscular
dystrophy. DMD patients treated with oxandrolone were
compared with a placebo group [26]; although patients
treated with oxandrolone did not experience the loss of
strength of the control group, the diﬀerence between both
groups was not signi�cant. �owever, the average �MT
(quantitative muscle testing of four muscles) showed a
signi�cant increase in patients treated with oxandrolone
compared with those treated with placebo. Besides the great
anabolic power of oxandrolone in DMD, the drug promotes
increased expression of genes that might partly explain its
eﬀect [27]. Skeletal muscles of mice with muscular dystrophy
have testosterone receptors with the same characteristics of
activity and aﬃnity as those of normal mice.
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In DMD patients, estrogen levels were higher than a
control group matched by age. LH levels were normal and
FSH levels were low [28]. e use of estrogens has already
been evaluated in DMD. In eleven DMD patients treated
with diethylstilbestrol, a reduction in the levels of CK and
LDH was observed with no analysis of the muscular strength
parameters [29]. Another study showed anabolic eﬀect of
diethylstilbestrol in 7 DMD patients [30]. Young female mdx
mice show less myonecrosis and more �ber regeneration�
mdx ovariectomized females show a reduction of �ber
regeneration. Older mdx females present extensive �brosis,
increase of the permeability of the sarcolemma, and marked
deposition of extracellular matrix components compared to
mdx males [31]. is increased regeneration of mdx females
at younger ages may be explained by a mitogenic eﬀect of
estrogen that binds to nuclear receptors. is eﬀect has been
con�rmed in vivo with estradiol activating the proliferation
of muscle satellite cells [32]. In spite of the fact that myoblasts
from mice express the estrogen receptor in vitro, estradiol
does not in�uence the proliferation of myoblasts [32]. It is
suggested that estrogen would act indirectly, by inducing
growth factors like IGF-1 and IL-6 [31, 32]. In our study,
we observed that the expression of glucocorticoid receptors
is reduced in the EDL muscle of dystrophic mice. As the
treatment with glucocorticoids increases the expression of
these receptors, we could speculate that this would be one
of the probable mechanisms of action of corticosteroids. We
also note that the expression of androgen receptors is reduced
in the quadriceps and the gastrocnemius of mice with a
mutation in the dystrophin gene. Since the expression of
these receptors increases with testosterone administration,
this would also be a likely bene�c mechanism of treatment
with androgens in muscular dystrophy.
Another observation from our study was that the expres-
sion of estrogen receptors was increased in the EDL (estrogen
alpha) and the quadriceps (estrogen beta) of dystrophicmice.
is eﬀect may explain the worst outcome of female mdx
mice, which present extensive �brosis, increased permeability
of the sarcolemma, and marked deposition of extracellular
matrix components, once they had been suﬀering a pro-
longed action of estrogens [33].
Another fact found, which requires more studies, was
the reduction in progesterone receptor expression in the
diaphragm of dystrophic mice compared with healthy mice.
5. Conclusion
is is a preliminary study and it represents the �rst study
of hormone receptors in diﬀerentmuscles of mdx mice. e
analysis of diﬀerent muscle groups showed that dystrophic
muscles have some signi�cant diﬀerences in hormone recep-
tor expression when compared to normal mice. Changes
in expression of hormone receptors in dystrophic muscles
reported here could explain some of the events related to the
pathophysiology of DMD and the response to the therapy
already described in the literature. Hence, carrying out more
studies on the hormone receptor expression in DMDpatients
would open new path for the discovery of new drugs that
might, more eﬀectively, slow the disease progression and
improve the quality of life of these patients.
Abbreviations
cDNA: Complementary deoxyribonucleic acid
CK: Creatine kinase
DMD: Duchenne muscular dystrophy
EDL: Extensor digitorum longus
FSH: Follicle-stimulating hormone
IGF1: Insulin growth factor 1
IL-6: Interleukin-6
LDH: Lactase dehydrogenase
LH: Luteinizing hormone
MMLV: Moloney murine leukemia virus reverse
transcriptase
mRNA: Messenger ribonucleic acid
PCR: Polymerase chain reaction
QTM: Quantitativemuscle testing of fourmuscles
RNA: Ribonucleic acid
RNaseOUT: Ribonuclease inhibitor
RT: Reverse transcriptase.
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